According to Taysha Gene Therapies's latest financial reports the company's current EPS (TTM) is -2,19ย โฌ. In 2022 the company made an earnings per share (EPS) of -3,63ย โฌ an increase over its 2021 EPS that were of -4,42ย โฌ.